PMV Pharmaceuticals Inc.

NASDAQ: PMVP · Real-Time Price · USD
1.50
-0.05 (-3.23%)
At close: Aug 15, 2025, 3:59 PM
1.49
-1.00%
After-hours: Aug 15, 2025, 05:54 PM EDT

PMV Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 1.62M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
32K n/a n/a n/a 372K 362K 359K 358K 369K 82K 160K 144K 179K 167K 407K 410K 71K 79K
Gross Profit
-32K n/a n/a n/a -372K -362K 1.26M -358K -369K -82K -160K -144K -179K -167K -407K -410K -71K -79K
Operating Income
-22.88M -21.56M -25.17M -21.89M -20.17M -18.22M -18.9M -19.63M -20.12M -21.48M -21.16M -19.38M -17.89M -18.62M -18.47M -15.1M -13.05M -11.67M
Interest Income
1.69M n/a 2.29M 2.62M 2.8M 2.95M 3.17M 2.98M 2.7M 2.33M 1.8M 1.12M 604K 229K 106K 102K 113K 128K
Pretax Income
-21.2M -19.63M -23M -19.15M -17.39M -15.27M -15.76M -16.64M -17.43M -19.13M -19.34M -18.24M -17.31M -18.43M -18.36M -14.99M -12.87M -11.6M
Net Income
-21.21M -17.44M -23M -19.23M -1.21M -15.27M -15.76M -16.64M -17.44M -16.78M -19.33M -18.23M -17.31M -18.43M -18.36M -15.01M -12.87M -11.6M
Selling & General & Admin
4.48M 4.12M 11.4M 4.94M 5.54M 5.04M 5.52M 6.04M 6.28M 6.41M 6.14M 5.71M 6.42M 6.78M 6.3M 5.93M 5.39M 4.17M
Research & Development
18.37M 17.44M 13.77M 16.95M 14.26M 12.82M 13.02M 13.59M 13.84M 15.07M 15.03M 13.67M 11.46M 11.84M 12.17M 9.16M 7.66M 7.5M
Other Expenses
n/a n/a n/a n/a -17K -1K -21K 4K -6K 27K 20K 13K -31K -41K 7K 3K 63K -52K
Operating Expenses
22.85M 21.56M 25.17M 21.89M 19.8M 17.86M 18.54M 19.63M 20.12M 21.48M 21.16M 19.38M 17.89M 18.62M 18.47M 15.1M 13.05M 11.67M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
22.88M 21.56M 25.17M 21.89M 20.17M 18.22M 18.9M 19.63M 20.12M 21.48M 21.16M 19.38M 17.89M 18.62M 18.47M 15.1M 13.05M 11.67M
Income Tax Expense
5K -2.2M n/a 74K -16.17M n/a -1K n/a 4K -2.35M -18K -9K -2K 2K 23K 19K -113K 4K
Shares Outstanding (Basic)
52.01M 51.95M 51.57M 51.57M 51.48M 51.45M 51.45M 49.05M 45.81M 45.77M 45.7M 45.62M 45.57M 45.47M 45.3M 45.3M 45.07M 44.79M
Shares Outstanding (Diluted)
52.01M 51.95M 51.57M 51.57M 51.48M 51.45M 51.45M 49.05M 45.81M 45.77M 45.7M 45.62M 45.57M 45.47M 45.3M 45.3M 45.07M 44.79M
EPS (Basic)
-0.41 -0.34 0.37 -0.37 -0.02 -0.3 -0.31 -0.34 -0.38 -0.42 -0.42 -0.4 -0.38 -0.41 -0.41 -0.33 -0.29 -0.26
EPS (Diluted)
-0.41 -0.34 0.37 -0.37 -0.02 -0.3 -0.31 -0.34 -0.38 -0.42 -0.42 -0.4 -0.38 -0.41 -0.41 -0.33 -0.29 -0.26
EBITDA
-21.17M -21.56M -25.13M -21.52M -19.8M -17.18M -18.54M -19.27M -19.75M -21.31M -21.09M -19.3M -17.8M -18.54M -18.39M -15.02M -12.98M -11.6M
EBIT
-21.2M -21.56M -25.17M -21.89M -20.17M -18.22M -18.9M -19.63M -20.12M -21.48M -21.16M -19.38M -17.89M -18.62M -18.47M -15.1M -13.05M -11.67M
Depreciation & Amortization
32K 37K 39K 371K 372K 362K 359K 358K 369K 82K 160K 144K 179K 167K 407K 410K 71K 79K